Nature Reviews Cancer

Papers
(The H4-Index of Nature Reviews Cancer is 76. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Computing brain metastasis impact762
Fructose takes a detour to feed cancer538
Combining spatial transcriptomics and AI to enhance brain tumour diagnosis521
INVADEseq to study the intratumoural microbiota at host single-cell resolution505
Exploiting metabolic cell death for cancer therapy472
Oncofetal reprogramming in tumour development and progression429
Implementing practice-changing progress for managing cancer of unknown primary429
Combinatorial strategies to target RAS-driven cancers395
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment356
Emerging strategies to investigate the biology of early cancer328
Claudin proteins as emerging therapeutic targets for solid tumours320
Mapping the prostate cell family tree317
Fighting cancer with fat305
3D chromatin architecture as a predictor of somatic mutations in cancer genomes286
Reply to ‘Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies’286
Connie J. Eaves (1944–2024)285
Avoiding cancer through collective behaviour283
How medical anthropology can contribute to cancer research271
Author Correction: Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma266
The recruitment of metastasis-associated monocytes264
The evolution of cancer and ageing: a history of constraint263
Tertiary lymphoid structures as hubs of antitumour immunity253
Translating premalignant biology to accelerate non-small-cell lung cancer interception250
Epithelial and stromal co-evolution and complicity in pancreatic cancer233
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies232
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel230
Nanoreceptors take down mutant p53225
Impersonating neurons218
Tumour EVPs disrupt liver function213
Defining a ‘cells to society’ research framework for appendiceal tumours205
AACR 2025203
Measuring HLA disruption using MHC Hammer200
No mutation, tumour initiation198
Persistence is key190
Thelpers? More like Ttroublemakers189
Gut microbes produce novel genotoxic metabolites181
Dendritic cells rise and shine179
Removing barriers to address sex differences in anticancer drug toxicity177
3D bioprinted cancer models: from basic biology to drug development174
Moonlighting functions of glucose metabolic enzymes and metabolites in cancer172
Rethinking ovarian cancer III: the past decade and future directions169
How chemokines organize the tumour microenvironment167
Bone voyage: immune crosstalk sets sail164
B-ring sterols to the rescue161
Visualizing intratumoural heterogeneity with EpicMIBI148
Double trouble for the tumour glycocode145
Identifying spatial cellular structures with SPACE-GM140
In-depth organoid profiling of pancreatic cancer134
Linking cell mechanical memory and cancer metastasis132
Beyond oncogenesis: the unexplored benefits of viruses in cancer immunity132
Context-dependent synthetic lethality — an emerging precision therapeutic approach131
Imaging the hallmarks of cancer125
Environmental endocrine disruptors: rethinking the origins of early-onset ER+ breast cancer118
Enhancer and metabolic rewiring by KMT2C–COMPASS or KMT2D–COMPASS family loss in cancer creates druggable vulnerabilities112
The path to leptomeningeal metastasis110
Metabolic interplays between the tumour and the host shape the tumour macroenvironment109
Opportunities and challenges of targeting cGAS–STING in cancer103
The immune microenvironment of colorectal cancer102
Regulatory T cells in the tumour microenvironment101
Leveraging the replication stress response to optimize cancer therapy100
Dynamics and specificities of T cells in cancer immunotherapy100
Understanding and addressing race disparities in childhood cancer outcomes99
Encoding spatial tumour dynamics with Starfysh94
Race influences the tumour microbiome90
Deciphering the cancer genome and epigenome90
ER stress sparks nerve pain89
Re-routing IgE for cancer therapy86
Being in the zone86
Polygenic scores in cancer85
Beat it!83
Advancing AI for multi-omics and clinical data integration in basic and translational cancer research82
Stem cells as an essential mediator of the exercise–tumorigenesis link80
Detection of cytokine-responsive cells using CyCLoPs79
RNA splicing dysregulation and the hallmarks of cancer78
Acetyl-CoA metabolism in cancer77
Targeted protein degradation for cancer therapy76
1.1269299983978